𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Estrogen receptor determination in percutaneous bone marrow biopsies of patients with metastatic breast cancer

✍ Scribed by Wortman, James E. ;Rundles, R. Wayne ;Moore, Joseph O. ;McCarty, Kenneth S. ;McCarty, Kenneth S.

Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
433 KB
Volume
7
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis

Estrogen receptor determination in metastatic breast cancer has been shown to be important in determining potential for response to endocrine therapy. One limitation to this procedure can be the availability of neoplastic material for receptor assay. This report describes patients in whom estrogen receptor status was determined using malignant cells obtained through routine posterior iliac crest bone marrow biopsy. The ability to obtain receptor data from percutaneous bone marrow biopsy specimens has proved to be of important in patients in whom other sites involved with tumor were not accessible.

πŸ“œ SIMILAR VOLUMES

Estrogen receptor profile of patients wi
Estrogen receptor profile of patients with breast cancer metastatic to bone marrow
✍ G. Thomas Budd πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 252 KB

The estrogen receptor (ER) profile of patients with breast cancer metastatic to bone marrow (BM) has not been widely reported. The charts of all patients having a diagnosis of breast cancer and undergoing bone marrow aspiration or biopsy at the Cleveland Clinic during the period of January 1980 thro

Comparative binding affinities of tamoxi
Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma: Correlation with blood levels in patients with metastatic breast cancer
✍ Carol Fabian; Lowell Tilzer; Larry Sternson πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 470 KB πŸ‘ 1 views

## Abstract The relative ability of the antiestrogen, tamoxifen, and its monohydroxy and desmethyl metabolites to displace tritiated estradiol from estrogen receptors isolated from human breast carcinoma was determined. 4‐Hydroxytamoxifen binds to the estrogen receptor with affinity equal to estrad